Rilzabrutinib for the Adult Participants With Chronic ITP Who Have Completed Phase 3 Study in Japan
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Rilzabrutinib
Related studies linked through entity extraction aliases.
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia
- Status
- RECRUITING
- Phase
- PHASE3
Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
- Status
- RECRUITING
- Phase
- PHASE3
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Effect of Mild and Moderate Hepatic Impairment on the Single-Dose Pharmacokinetics of Rilzabrutinib (PRN1008)
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics (PK) of Rilzabrutinib (PRN1008) in Healthy Japanese and Caucasian Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine
- Status
- COMPLETED
- Phase
- PHASE2
Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe Asthma
- Status
- COMPLETED
- Phase
- PHASE2
Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Open Label Two-Arm Study to Evaluate Rilzabrutinib in IgG4-Related Disease Participants
- Status
- COMPLETED
- Phase
- PHASE2
A Study of PRN1008 in Patients With Pemphigus
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)
- Status
- COMPLETED
- Phase
- PHASE2